Answers are grounded in this paper and cite their sources.
Qualitative study explores views on TKI dose reduction in CML, suggesting shared decision-making improves treatment burden.
Patients and healthcare providers have positive views on TKI dose reduction to improve the burden of CML treatment. Acceptance is shaped by their beliefs and concerns, while successful implementation depends on addressing practical needs and shared-decision making.
No takes yet. Share an insight, caveat, or question.
Lokhorst et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: